The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nucleic Acids Research

• Publication date

  2003-09-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/NAR/GKG746PMID 12954760PMCID PMC203329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of base specificity of multiple ribonucleases from crude samples

  2004cited by this paper
• Residues Involved in the Catalysis, Base Specificity, and Cytotoxicity of Ribonuclease from Rana catesbeianaBased upon Mutagenesis and X-ray Crystallography*

  2003cited by this paper
• Solution structure of the cytotoxic RNase 4 from oocytes of bullfrog Rana catesbeiana.

  2003cited by this paper
• Contribution of chain termini to the conformational stability and biological activity of onconase.

  2001cited by this paper
• RefSeq and LocusLink: NCBI gene-centered resources

  2001cited by this paper
• Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog).

  2000cited by this paper
• A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure.

  2000cited by this paper
• Machine learning approaches for the prediction of signal peptides and other protein sorting signals.

  1999cited by this paper
• Protein identification and analysis tools in the ExPASy server.

  1999cited by this paper
• The three-dimensional structure of human RNase 4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity.

  1999cited by this paper
• The solution structure of a cytotoxic ribonuclease from the oocytes of Rana catesbeiana (bullfrog).

  1998cited by this paper
• The Rana catesbeiana rcr Gene Encoding a Cytotoxic Ribonuclease

  1998cited by this paper
• Biochemistry of frog ribonucleases

  1998cited by this paper
• Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.

  1998influential reference
• Ribonuclease A.

  1998cited by this paper
• 2-D proteome analysis protocols

  1998cited by this paper
• 9 – Pancreatic Ribonucleases

  1997cited by this paper
• Molecular cloning of four novel murine ribonuclease genes: unusual expansion within the ribonuclease A gene family.

  1997cited by this paper
• Large-scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxic activity against tumor cells.

  1996cited by this paper
• Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.

  1996cited by this paper
• A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.

  1996cited by this paper
• Recombinant Human Eosinophil Cationic Protein

  1995cited by this paper
• Toxicity of an antitumor ribonuclease to Purkinje neurons

  1994cited by this paper
• Yolk granules are the major compartment for bullfrog (Rana catesbeiana) oocyte-specific ribonuclease.

  1994cited by this paper
• Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity.

  1994cited by this paper
• New and cryptic biological messages from RNases.

  1993cited by this paper
• A pyrimidine-guanine sequence-specific ribonuclease from Rana catesbeiana (bullfrog) oocytes.

  1992cited by this paper
• Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity.

  1992cited by this paper
• Comparative base specificity, stability, and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana.

  1991cited by this paper
• The production of polyclonal and monoclonal antibodies in mice using novel immunization methods.

  1989cited by this paper
• Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid.

  1989cited by this paper
• Expression of Met-(-1) angiogenin in Escherichia coli: conversion to the authentic less than Glu-1 protein.

  1988cited by this paper
• Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides.

  1987cited by this paper
• An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes.

  1987cited by this paper
• The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity.

  1986cited by this paper
• Characteristic ribonucleolytic activity of human angiogenin.

  1986cited by this paper
• Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.

  1986cited by this paper
• Detection of enzymatic activities in sodium dodecyl sulfate-polyacrylamide gels: DNA polymerases as model enzymes.

  1983influential reference
• In vitro studies on selective inhibition of tumor cell growth by seminal ribonuclease.

  1980cited by this paper

• Determination of an Optimal Temperature Range of Methionine Aminopeptidase from Thermus thermophilus

  2024cites this paper
• Recombinant Ranpirnase enhances the expression of co-transfected mRNA by modulating cellular metabolic activity

  2023cites this paper
• Obtaining Overstable Methionine Aminopeptidase for the Removal of Methionine From Recombinant Proteins

  2023cites this paper
• The Potential of a Protein Model Synthesized Absent of Methionine

  2022cites this paper
• Strategies to Enhance Periplasmic Recombinant Protein Production Yields in Escherichia coli

  2021cites this paper
• Diverse protein manipulations with genetically encoded glutamic acid benzyl ester

  2021cites this paper
• Fungal effector SIB1 of Colletotrichum orbiculare has unique structural features and can suppress plant immunity in Nicotiana benthamiana

  2021cites this paper
• High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting

  2019cites this paper
• Solution structure and base specificity of cytotoxic RC-RNase 2 from Rana catesbeiana.

  2015cites this paper
• A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells

  2015cites this paper
• Disseny, construcció i caracterització de zimògens de ribonucleases

  2015influential citation
• Stability and folding of amphibian ribonuclease A superfamily members in comparison with mammalian homologues

  2014cites this paper
• Linked Production of Pyroglutamate-Modified Proteins via Self-Cleavage of Fusion Tags with TEV Protease and Autonomous N-Terminal Cyclization with Glutaminyl Cyclase In Vivo

  2014cites this paper
• Towards Tricking a Pathogen’s Protease into Fighting Infection: The 3D Structure of a Stable Circularly Permuted Onconase Variant Cleavedby HIV-1 Protease

  2013cites this paper
• 22. ImmunoRNase Fusions

  2013cites this paper
• A Novel Cationic Ribonuclease with Antimicrobial Activity from Rana dybowskii

  2011influential citation
• Human pyroglutamyl peptidases and their involvement in Alzheimer's disease

  2011cites this paper
• linical Development pirnase ( Frog RNase ) Targeted with a Humanized , rnalizing , Anti – Trop-2 Antibody Has Potent Cytotoxicity Ther inst Diverse Epithelial Cancer Cells

  2010cites this paper
• Kinetic and structural characterization of bacterial glutaminyl cyclases from Zymomonas mobilis and Myxococcus xanthus

  2010cites this paper
• Ranpirnase (Frog RNase) Targeted with a Humanized, Internalizing, Anti–Trop-2 Antibody Has Potent Cytotoxicity against Diverse Epithelial Cancer Cells

  2010cites this paper
• Ribonucleases as potential modalities in anticancer therapy.

  2009cites this paper
• Optimized procedures for producing biologically active chemokines.

  2009cites this paper
• Secretory expression of glycosylated and aglycosylated mutein of onconase from Pichia pastoris using different secretion signals and their purification and characterization.

  2009cites this paper
• Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.

  2009cites this paper
• Tools for analyzing and predicting N‐terminal protein modifications

  2008cites this paper
• Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

  2008cites this paper
• The interdependence between catalytic activity, Conformational stability and cytotoxicity of onconase

  2007cites this paper
• Use of signal sequences as an in situ removable sequence element to stimulate protein synthesis in cell-free extracts

  2006cites this paper
• Contribution of structural peculiarities of onconase to its high stability and folding kinetics.

  2006cites this paper
• Roles of N-terminal pyroglutamate in maintaining structural integrity and pKa values of catalytic histidine residues in bullfrog ribonuclease 3.

  2006cites this paper
• Differentiation of Leishmania major is impaired by over-expression of pyroglutamyl peptidase I.

  2006cites this paper
• Snake venom glutaminyl cyclase.

  2006cites this paper
• Transfer RNA Cleavages by Onconase Reveal Unusual Cleavage Sites*

  2006cites this paper
• Studies on cathepsin B of Eimeria tenella and pyroglutamyl peptidase of Leishmania major

  2005cites this paper
• Removal of N‐terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase

  2004cites this paper
• Effect of N-terminal and Met23 Mutations on the Structure and Dynamics of Onconase*

  2004cites this paper